Veterinary Industry in UK Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The UK Veterinary Healthcare Market Report is Segmented by Product (Therapeutics, Diagnostics, and Other Products) and Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animal Types). The Report Offers the Value (USD) for the Above Segments.

Veterinary Industry in UK Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

United Kingdom Veterinary Healthcare Market Size

View Global Report
United Kingdom Veterinary Healthcare Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 1.87 Billion
Market Size (2030) USD 2.62 Billion
CAGR (2025 - 2030) 6.94 %
Market Concentration Low

Major Players

United Kingdom Veterinary Healthcare Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of United Kingdom Veterinary Healthcare Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

United Kingdom Veterinary Healthcare Market Analysis

The United Kingdom Veterinary Healthcare Market size is estimated at USD 1.87 billion in 2025, and is expected to reach USD 2.62 billion by 2030, at a CAGR of 6.94% during the forecast period (2025-2030).

The major factors driving the market's growth include the rise in pet adoptions, novel product developments in the veterinary industry, and increasing initiatives by governments and animal welfare associations in the region.

For instance, in August 2023, the Biotechnology and Biological Sciences Research Council (BBSRC) and the Department for Environment, Food and Rural Affairs (Defra) allocated GBP 9 million (USD 11.51 million) in funding for the second phase of the pioneering endemic livestock disease initiative. Similarly, in May 2023, the Biotechnology and Biological Sciences Research Council (BBSRC) received funding to mechanistically understand host-pathogen interactions in farmed animals and tackle veterinary antimicrobial resistance (Vet-AMR). The project comprised a UK component funded by BBSRC and an Indian component funded by DBT, with a total of GBP 5 million (USD 6.39 million) allocated from BBSRC and matched resources from DBT for successful Indian applicants.

Additionally, increasing product launches in the United Kingdom's veterinary industry may significantly contribute to market growth. For instance, in October 2023, MSD launched Bovilis Nasalgen-C, an intranasal live bovine coronavirus (BCoV) vaccine, in the United Kingdom. Bovilis Nasalgen-C is an immunization product designed for neonatal calves to mitigate clinical symptoms of upper respiratory tract disease and reduce nasal viral shedding caused by BCoV infection. Similarly, in April 2022, Vetoquinol introduced Felpreva to the UK market. Felpreva is a quarterly feline spot-on parasiticide targeting endoparasites and ectoparasites. It offers a solution to decrease the frequency of treatments and minimize stressful interactions between pet owners and their cats.

In conclusion, the factors mentioned above, such as increasing investments and product launches, are expected to boost the growth of the UK veterinary healthcare market during the forecast period. However, counterfeit medicines and the increasing cost of animal testing and veterinary services are expected to hinder the market's growth during the study period.

United Kingdom Veterinary Healthcare Industry Overview

The UK veterinary healthcare market is moderately competitive, with the presence of several global and international market players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are launching new products, while others are distributing the products. Some of the companies that are currently dominating the market are Bayer AG, Boehringer Ingelheim, MSD Animal Health, Virbac Corporation, and Ceva Santé Animale.

United Kingdom Veterinary Healthcare Market Leaders

  1. Boehringer Ingelheim

  2. MSD Animal Health

  3. Virbac Corporation

  4. Ceva Santé Animale

  5. Elanco

  6. *Disclaimer: Major Players sorted in no particular order
United Kingdom Veterinary Healthcare Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

United Kingdom Veterinary Healthcare Market News

  • April 2024: Antech launched a new, rapid canine cancer test for use in practice in the United Kingdom. The Nu.Q Canine Cancer Test is a technology that measures circulating nucleosomes in order to enable earlier cancer detection in some of the most common types of canine cancers.
  • February 2024: ECO Animal Health Group PLC informed that the ECOVAXXIN trademark was approved by the European Union. The registration for ECOVAXXIN provides trademark branding for a family of vaccine products. ECOVAXXIN is a master trademark and will protect all ECO's forthcoming vaccine products. Starting in 2025, the company plans to market its vaccine products in multiple jurisdictions, with multiple planned launches over the next ten-year period.

UK Veterinary Healthcare Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumption and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare
    • 4.2.2 Increasing Pet Ownership
    • 4.2.3 Increasing Productivity at the Risk of Emerging Zoonosis
  • 4.3 Market Restraints
    • 4.3.1 Use of Counterfeit Medicines
    • 4.3.2 Increasing Pet Care Costs
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product
    • 5.1.1 Therapeutics
    • 5.1.1.1 Vaccines
    • 5.1.1.2 Parasiticides
    • 5.1.1.3 Anti-infectives
    • 5.1.1.4 Medical Feed Additives
    • 5.1.1.5 Other Therapeutics
    • 5.1.2 Diagnostics
    • 5.1.2.1 Immunodiagnostic Tests
    • 5.1.2.2 Molecular Diagnostics
    • 5.1.2.3 Diagnostic Imaging
    • 5.1.2.4 Clinical Chemistry
    • 5.1.2.5 Other Diagnostics
  • 5.2 By Animal Type
    • 5.2.1 Dogs and Cats
    • 5.2.2 Horses
    • 5.2.3 Ruminants
    • 5.2.4 Swine
    • 5.2.5 Poultry
    • 5.2.6 Other Animal Types

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boehringer Ingelheim International GmbH
    • 6.1.2 Ceva Animal Health Inc.
    • 6.1.3 Covetrus Inc.
    • 6.1.4 ECO Animal Health Ltd
    • 6.1.5 Elanco
    • 6.1.6 KRKA UK Ltd
    • 6.1.7 MSD Animal Health
    • 6.1.8 TVM UK
    • 6.1.9 Vetoquinol UK Limited
    • 6.1.10 Virbac Corporation
    • 6.1.11 Zoetis Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

United Kingdom Veterinary Healthcare Industry Segmentation

As per the report's scope, veterinary healthcare can be defined as the science associated with diagnosing, treating, and preventing animal diseases. The increasing importance of the production of livestock animals is generating growth in the veterinary healthcare market. The UK veterinary healthcare market is segmented by product and animal type. The product segment is further segmented into therapeutics and diagnostics. The therapeutics segment is further segmented into vaccines, parasiticides, anti-infectives, medical feed additives, and other therapeutics, while the diagnostic segment is divided into immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, and other diagnostics. The animal type segment is further divided into dogs and cats, horses, ruminants, swine, poultry, and other animals. The report offers the value (USD) for the above segments.

By Product Therapeutics Vaccines
Parasiticides
Anti-infectives
Medical Feed Additives
Other Therapeutics
Diagnostics Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type Dogs and Cats
Horses
Ruminants
Swine
Poultry
Other Animal Types
Need A Different Region or Segment?
Customize Now

UK Veterinary Healthcare Market Research FAQs

How big is the United Kingdom Veterinary Healthcare Market?

The United Kingdom Veterinary Healthcare Market size is expected to reach USD 1.87 billion in 2025 and grow at a CAGR of 6.94% to reach USD 2.62 billion by 2030.

What is the current United Kingdom Veterinary Healthcare Market size?

In 2025, the United Kingdom Veterinary Healthcare Market size is expected to reach USD 1.87 billion.

Who are the key players in United Kingdom Veterinary Healthcare Market?

Boehringer Ingelheim, MSD Animal Health, Virbac Corporation, Ceva Santé Animale and Elanco are the major companies operating in the United Kingdom Veterinary Healthcare Market.

What years does this United Kingdom Veterinary Healthcare Market cover, and what was the market size in 2024?

In 2024, the United Kingdom Veterinary Healthcare Market size was estimated at USD 1.74 billion. The report covers the United Kingdom Veterinary Healthcare Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the United Kingdom Veterinary Healthcare Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

UK Veterinary Healthcare Industry Report

The veterinary healthcare market in the United Kingdom, driven by advanced technology and increasing pet ownership, is showing promising growth trajectories, particularly in the molecular diagnostics and vaccines segments. Enhanced by technologies like PCR and microarrays, the molecular diagnostics segment is gaining momentum due to its high sensitivity and fast results, alongside innovative product launches from leading animal health companies in the UK. Meanwhile, the vaccines segment is projected to witness substantial growth, powered by continuous innovations and the development of genetically engineered vaccines that boost animal immunity. Significant investments are being made to enhance animal health and prevent diseases among companion animals, further bolstering market growth. For detailed statistics on market share, size, and revenue growth, along with a forecast outlook, refer to the latest Mordor Intelligence™ industry reports on the UK veterinary healthcare sector. Get a sample of this industry analysis as a free report PDF download.

UK Veterinary Healthcare Market Report Snapshots